Literature DB >> 3683730

Stereoselective uptake of the GABA-transaminase inhibitors gamma-vinyl GABA and gamma-acetylenic GABA into neurons and astrocytes.

A Schousboe1, O M Larsson, N Seiler.   

Abstract

The cellular uptake of the GABA-transaminase inhibitors gamma-vinyl GABA (GVG) and gamma-acetylenic GABA (GAG) was studied in cultured neurons and astrocytes. By the use of the individual enantiomers R- and S-GVG and R- and S-GAG it could be shown that in both cell types only the S-enantiomers could be actively transported. Comparing neurons and astrocytes only neurons exhibited a high affinity uptake system for S-GVG (Km 78.2 +/- 20.3 microM; Vmax 0.71 +/- 0.06 nmol.min-1.mg-1 cell protein). In case of S-GAG it could not be established with certainty whether the neuronal uptake was of the high affinity type. Both GVG and GAG were studied as inhibitors of GABA uptake into neurons and astrocytes. S-GVG and S-GAG were found to be weak inhibitors of GABA uptake suggesting that S-GVG is not transported by the GABA carrier in neurons. The finding of a much more efficient uptake of S-GVG into neurons than into astrocytes is in line with the previous observation that neuronal GABA-T is more sensitive than astrocytic GABA-T to S-GVG.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3683730     DOI: 10.1007/bf00965769

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.

Authors:  M J Jung; B Lippert; B W Metcalf; P J Schechter; P Böhlen; A Sjoerdsma
Journal:  J Neurochem       Date:  1977-04       Impact factor: 5.372

2.  Rat cortical neurons in cell culture: culture methods, cell morphology, electrophysiology, and synapse formation.

Authors:  M A Dichter
Journal:  Brain Res       Date:  1978-06-30       Impact factor: 3.252

3.  Developmental changes of putreanine in vertebrate brains.

Authors:  N Seiler; S Sarhan; B Knodgen
Journal:  Int J Dev Neurosci       Date:  1985       Impact factor: 2.457

4.  Brain specific synaptosomal membrane proteins demonstrated by crossed immunoelectrophoresis.

Authors:  O S Jorgensen; E Bock
Journal:  J Neurochem       Date:  1974-10       Impact factor: 5.372

Review 5.  The pharmacology of GABA-transaminase inhibitors.

Authors:  M G Palfreyman; P J Schechter; W R Buckett; G P Tell; J Koch-Weser
Journal:  Biochem Pharmacol       Date:  1981-04-15       Impact factor: 5.858

6.  Lack of stringent stereospecificity in the inactivation of pyridoxal phosphate-dependent enzymes by suicide-substrates.

Authors:  C Danzin; M J Jung
Journal:  Prog Clin Biol Res       Date:  1984

7.  Changes in the uptake of GABA and taurine during neuronal and glial maturation.

Authors:  J Borg; N Ramaharobandro; J Mark; P Mandel
Journal:  J Neurochem       Date:  1980-05       Impact factor: 5.372

8.  gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice.

Authors:  M J Jung; B Lippert; B W Metcalf; P Böhlen; P J Schechter
Journal:  J Neurochem       Date:  1977-11       Impact factor: 5.372

9.  Ion dependency of uptake and release of GABA and (RS)-nipecotic acid studied in cultured mouse brain cortex neurons.

Authors:  O M Larsson; J Drejer; L Hertz; A Schousboe
Journal:  J Neurosci Res       Date:  1983       Impact factor: 4.164

10.  Metabolic inhibitors and subcellular distribution of GABA.

Authors:  S Sarhan; N Seiler
Journal:  J Neurosci Res       Date:  1979       Impact factor: 4.164

View more
  7 in total

1.  Passage of S(+) and R(-) gamma-vinyl-GABA across the human isolated perfused placenta.

Authors:  J C Challier; E Rey; T Bintein; G Olive
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

Review 2.  Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.

Authors:  O A Petroff; D L Rothman
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

3.  Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.

Authors:  U Eckstein-Ludwig; J Fei; W Schwarz
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 4.  Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.

Authors:  S M Grant; R C Heel
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 5.  Primary cultures of astrocytes: their value in understanding astrocytes in health and disease.

Authors:  Sofie C Lange; Lasse K Bak; Helle S Waagepetersen; Arne Schousboe; Michael D Norenberg
Journal:  Neurochem Res       Date:  2012-08-28       Impact factor: 3.996

6.  Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects.

Authors:  Dana C Walters; Erwin E W Jansen; Garrett R Ainslie; Gajja S Salomons; Madalyn N Brown; Michelle A Schmidt; Jean-Baptiste Roullet; K M Gibson
Journal:  Pharmacol Res Perspect       Date:  2019-01-07

7.  Monitoring vigabatrin in head injury patients by cerebral microdialysis: obtaining pharmacokinetic measurements in a neurocritical care setting.

Authors:  Richard J Shannon; Ivan Timofeev; Jürgens Nortje; Peter J Hutchinson; Keri L H Carpenter
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.